instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: Swedish Thunberg said on Instagram she had now recovered from symptoms milder than her latest cold, and may not have suspected COVID-19 had it not been for her father, who had travelled with her, developing more severe symptoms. “Many (especially young people) might not notice any symptoms at all, or very mild symptoms. Then they don’t know they have the virus and can pass it on to people in risk groups,” she said. “We who don’t belong to a risk group have an enormous responsibility, our actions can be the difference between life and death for many others. Please keep that in mind, follow the advice from experts and your local authorities and #StayAtHome to slow the spread of the virus.”  The founder of the Fridays for Future youth movement said she had not been tested for the virus but given the combined symptoms and circumstances it was very likely she had it. She had self isolated because she had visited countries hit by coronavirus infection. Fridays for Future calls on politicians to listen to climate scientists and take urgent action to against global warming. Claim: Greta Thunberg says probably had COVID-19, urges #StayAtHome.
answer:
Teen climate activist Greta Thunberg said on Tuesday that while self-isolating after recent travels in Europe she probably came down with COVID-19, and urged other young people to stay at home too if even just a little unwell, to help stop the coronavirus.


question:
Paragraph: The lawsuit marks the first multi-plaintiff trial in the litigation over whether glyphosate, Roundup’s active ingredient, is carcinogenic, and is the first trial outside of California. It is being held in St. Louis, where Monsanto was headquartered before Bayer bought the company in a $63 billion deal in 2018. Three consecutive juries found the company liable for causing cancer with damages of tens of millions of dollars awarded to each plaintiff. Bayer is appealing those verdicts. Court-appointed mediator Ken Feinberg has put the number of Roundup cancer claimants at more than 75,000 while Bayer said the claims it has been served with in court were below 50,000. Bayer’s share price has tumbled since the first verdict in August 2018 but the stock rose 3% on Friday after Bloomberg reported a possible out-of-court settlement with some plaintiffs that could lead to a total payout of about $10 billion. While traders said the market likes the idea of Bayer settling the litigation, some cautioned that the prospect of a comprehensive deal remained uncertain. Analysts have estimated the size of any such settlement at $8-$12 billion. While most plaintiffs’ lawyers have agreed to postpone trials pending negotiations, some have decided to pursue their clients’ day in court. The case in Missouri’s Circuit Court for the 22nd Judicial Circuit of the City of St. Louis is scheduled to last several weeks, with both sides presenting extensive scientific evidence through expert witnesses. Bayer denies all allegations that Roundup or glyphosate causes cancer, saying decades of independent studies have shown the world’s most widely used weed killer to be safe for human use and noting that regulators around the world have approved the product. “At the end of the day, this trial should come down to the weight of the science, and we remain confident in the extensive scientific record and regulatory assessments that support the safety of our glyphosate-based herbicides and that they do not cause cancer,” the company said in a statement. Several court cases have been postponed by both parties in the past to expedite settlement talks. By pursuing the St. Louis trail The Miller Firm LLC, a key player in the litigation, is seeking to increase pressure on Bayer. The case involves the claims of Bryce Batiste from Louisiana, Ann Meeks from Florida, Glen Ashelman from Pennsylvania and Christopher Wade, a St. Louis resident. All four have been diagnosed with non-Hodgkin’s lymphoma, a blood cell cancer that plaintiffs in the litigation allege is caused by Roundup. Some legal experts said Bayer could benefit from a home advantage in the St. Louis trial, where Monsanto has century-old roots. But juries in the city are also known to dole out massive damages awards against large corporations. Claim: Bayer faces fourth U.S. Roundup cancer trial in Monsanto's hometown.
answer:
Bayer AG is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday.


question:
Paragraph: E-cigarettes have been marketed as tools to help smokers quit, but rising use among youth in the United States and a spate of severe lung illnesses tied to the devices have triggered a backlash and heightened regulatory scrutiny. The U.S. Centers for Disease Control and Prevention has in the past advised consumers to avoid the devices, but the latest recommendation focused on THC products follows nationwide data that pointed to a large number of cases related to the use of the high-inducing component of marijuana. The CDC and state health officials, along with other health agencies, are investigating 805 confirmed and probable cases and 12 deaths so far from a mysterious respiratory illness tied to vaping, as of the latest update on Thursday. According to the research published by CDC on Friday, 514 of the 805 patients knew about substances used in their vaping products, with nearly 77% using THC-containing vapes. However, this does not narrow the focus of the investigation as some users have also reported using e-cigarettes with just nicotine, CDC’s principal deputy director Anne Schuchat told reporters on Friday. The data showed that 56.8% used nicotine in their vapes, while 16% used vapes containing just nicotine in the 30 days preceding their symptoms. “We do not know yet what exactly is making people sick, for example, whether particular solvents or adulterants are leading to lung injury, or whether cases stem from a single supplier or multiple ones,” Schuchat said. Separate data from Wisconsin and Illinois showed that although no single brand name was reported by all patients, two-thirds of consumers reported using a prefilled THC cartridge under the brand name “Dank Vapes”. A study published in the New England Journal of Medicine earlier this month found that more than half of lung illness patients extensively interviewed in Wisconsin and Illinois reported having used the “Dank Vapes” brand. Claim: U.S. CDC recommends against using vapes with marijuana ingredient.
answer:

People should stop using e-cigarettes, especially those with marijuana ingredient tetrahydrocannabinol (THC), U.S. public health officials recommended on Friday, as an investigation into illnesses and deaths related to vaping deepens.